Custom Peptide Libraries
AnaSpec CEF Control Peptide Pool, (1 mg)
CEF Control Peptide Pool, (1 mg) This product contains 0.03 mg (net) of the 32 CEF peptides for a total of 1 mg in one vial. Used in the stimulation of IFNy release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays.
Mabtech Inc PepPool: CMV (CD4 and CD8), human, 25 μg of each peptide, lyophilized, 42 peptides, >95% purity, MHC class I: 28, MHC class II: 14
PepPool: CMV (CD4 and CD8), human, 25 μg of each peptide, lyophilized, 42 peptides, >95% purity, MHC class I: 28, MHC class II: 14
Bioss KD-Validated Trophoblast Glyco
Trophoblast Glycoprotein Primary Antibody Unconjugated Public Immunogen Range 230-280/366 Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
Cayman Chemical 1 3DIlnoloyl2oloyl Glyc 50mg
A triacylglycerol; has been found in grape seed, pumpkin seed, soybean, sunflower, and wheat germ oils
Biolegend Spark YGTM 581 anti-mouse I-A/
Spark YG™ 581 anti-mouse I-A/I-E [M5/114.15.2]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg
![Biolegend TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502551028.png-250.jpg)
Biolegend TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug
TotalSeq™-C1018 anti-human HLA-DR, DP, DQ [Tü39]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: PG; Size: 10 ug
Cell Signaling Technology SARS-CoV-2 Spike Protein Serological IgM ELISA Kit 20 Kit
SARS-CoV-2 Spike Protein Serological IgM ELISA Kit 20 Kit
Cayman Chemical 1 3DIpalmItoyl2Oleoyl Glyc 5mg
A triacylglycerol; has been found in cocoa butter, Chinese tallow butter, and the palm stearin fraction of palm oil
Biolegend TotalSeqTM-B0117 anti-mouse I-
TotalSeq™-B0117 anti-mouse I-A/I-E [M5/114.15.2]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: PG; Size: 10 μg
Cayman Chemical ntISARSCoV2 SpIke Glycopr 1ea
Anti-SARS-CoV-2 Spike Glycoprotein RBD IgG Negative Control has been tested and formulated to work exclusively with Cayman’s Anti-SARS-CoV-2 Spike Glycoprotein RBD IgG ELISA Kit (Item No. 502111).
STEMCELL Technologies EBV HLA Class I Control Peptid, 1 Unit
Epstein-Barr virus EBV control peptide pool for immune cell activation
Genscript Corporation SARS-CoV-2 Spike protein RBD
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19) the respiratory illness responsible for the COVID-19 pandemic SARS-CoV-2 also known as 2019-nCoV is a positive-sense single-stranded RNA virus and is believed to have zoonotic origins and has close genetic similarity to bat coronaviruses The receptor binding domain (RBD) of spike protein of the SARS-CoV-2 virus binds Angiotensin-Converting Enzyme 2 (ACE2) to invade the host cells Based on structural biology studies the RBD can be oriented either in the up/standing or down/lying state with the up/standing state associated with higher pathogenicity